Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
Veröffentlicht: 17.03.2026 um 20:14 Uhr, prnewswire.co.uk+14699457679
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
en | boerse | 68735125 |
